GnRH agonist in frozen embryo transfer
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether adding a GnRH agonist medication before a frozen embryo transfer can improve success rates. It may help women undergoing their first or second frozen embryo transfer who have good quality embryos.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 20 and 39 years old
- Be having a frozen embryo transfer with hormone replacement therapy
- Have at least one good quality embryo (grade 3BB or higher)
- Have a uterine lining at least 7 mm thick on the day you start progesterone
- Have a BMI between 18 and 35
- This is your first or second frozen embryo transfer
- Willing to give written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using two medications (hCG and GnRH agonist) together as a trigger improves success rates for frozen embryo transfers in natural menstrual cycles. It may help women who are preparing for this procedure.
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
This study tests whether using a hormone medication (GnRH agonist) before a frozen embryo transfer helps women with adenomyosis. If you have adenomyosis and are planning a frozen embryo transfer, this trial will help compare results with or without the pre-treatment.
This study tests whether a hormone called GnRH can improve success rates during IVF (in vitro fertilization) by supporting the embryo after transfer. If you're having IVF for the first to third time and your doctor is considering different support methods, this trial may explore options for you.
This trial studies whether adjusting the length of pre-treatment with a hormone blocker (GnRH agonist) and adding letrozole before a frozen embryo transfer can improve pregnancy outcomes for people with adenomyosis.
This trial looks at whether frozen embryo transfer can help women with adenomyosis (a condition where the inner lining of the uterus grows into its muscle wall) who have trouble getting pregnant. It aims to understand if this method improves pregnancy chances.
Hear when a new GnRH Agonist trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.